British Patient Capital (BPC) has launched its Life Sciences Investment Programme, which will make investments in UK-focused, later-stage life sciences funds.
Fifth Secondaries Market Report also reveals that 97% of secondaries investors are participating in GP-leds
French sponsor beats Ardian and Antin in race for a majority stake in French veterinary chain
Fund is headed by Kirsten Connell and Maria Rotilu and has extended its hard cap to GBP 15m following a first close
BGF exits energy markets consultancy following minority stake investment in 2017